Skip to content

New resistance becoming rarer as more patients achieve undetectable HIV viral load

Most NNRTI-experienced patients in southern Africa will benefit from etravirine

US guidelines now favour treatment at CD4 cell counts between 350 and 500; above 500 not ruled out

Transmitted drug-resistant HIV stabilising in Europe

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

Delays in switching treatment: NRTI resistance can be slower to emerge than expected

Cheap viral load test is as reliable as standard: Botswana places large order

Triple-drug treatment during pregnancy reduces risk of nevirapine resistance

Updated HIV care guidelines issued in USA